CyFlow CD154 PE
品番 | AG649313 | ||
---|---|---|---|
抗体名 | Anti-Hu CD154 PE,24-31 | ||
包装単位 | 100 tests | ||
濃度 | - | ||
容量 | 1 ml | ||
関連製品 (アイソタイプコントロール) |
Mouse IgG1 PE (BV655324) |
||
反応性|交差吸着 | Human | Non-Human Primates | レーザー | Blue, Green, Yellow |
抗原 | CD154, CD40L | 最大蛍光波長 | 576 nm |
クローン | 24-31 | 最大励起波長 | 496 nm, 565 nm |
ホスト | Mouse | 標識/Format | PE |
アイソタイプ | IgG1 | 研究分野 | Immunophenotyping |
クローナリティ | monoclonal | 用途 | Flow cytometry |
Anti-Hu CD154 PE,24-31
特異性
The mouse monoclonal antibody 24-31 recognizes CD154/CD40L antigen, a 39 kDa cell surface type II glycoprotein expressed predominantly on activated CD4+ lymphocytes.
抗原情報
CD154 / CD40L (CD40 ligand) is a member of the tumor necrosis factor family, and is expressed primarily on activated CD4+ lymphocytes, but also on mast cells, basophils, eosinophils and human dendritic cells. Its counter-receptor CD40 is expressed on antigen presenting cells, including dendritic cells, macrophages, and B cells, and also on fibroblasts. Triggering of CD40 by CD40L causes maturation of dendritic cells and upregulation of antigen presentation in functions of the MHC and costimulatory molecules. CD40L also functions as a direct stimulating factor for T cells. CD40L plays also roles e.g. in antibody class switching and modulation of apoptosis in the germinal center.
利用方法
The reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 10 µl reagent / 100 µl of whole blood or 10^6 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.
保存方法
Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
安定性情報
Do not use after expiration date stamped on vial label.
レファレンス
• Barnhart B, Ford GS, Bhushan A, Song C, Covey LR: A polymorphic CD40 ligand (CD154) molecule mediates CD40‑dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions. Immunology. 2000·Jan; 99(1):54‑61. <·PMID:·10651941·>
• Berner B, Wolf G, Hummel KM, Müller GA, Reuss-Borst MA: Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis. Ann·Rheum·Dis. 2000·Mar; 59(3):190‑5. <·PMID:·10700427·>
• Brams P, Black A, Padlan EA, Hariharan K, Leonard J, Chambers-Slater K, Noelle RJ, Newman R: A humanized anti‑human CD154 monoclonal antibody blocks CD154‑CD40 mediated human B cell activation. Int·Immunopharmacol. 2001·Feb; 1(2):277‑94. <·PMID:·11360929·>
• Fernandes MS, Gomes EM, Butcher LD, Hernandez-Alcoceba R, Chang D, Kansopon J, Newman J, Stone MJ, Tong AW: Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgene. Clin·Cancer·Res. 2009·Aug·1; 15(15):4847‑56. <·PMID:·19622582·>
• Grammer AC, McFarland RD, Heaney J, Darnell BF, Lipsky PE: Expression, regulation, and function of B cell‑expressed CD154 in germinal centers. J·Immunol. 1999·Oct·15; 163(8):4150‑9. <·PMID:·10510350·>
• Kornbluth RS, Kee K, Richman DD: CD40 ligand (CD154) stimulation of macrophages to produce HIV‑1‑suppressive beta‑chemokines. Proc·Natl·Acad·Sci·USA. 1998·Apr·28; 95(9):5205‑10. <·PMID:·9560254·>
• Kum WW, Hung RW, Cameron SB, Chow AW: Temporal sequence and functional implications of V beta‑specific T cell receptor down‑regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin‑1. J·Infect·Dis. 2002·Feb·15; 185(4):555‑60. <·PMID:·11865410·>
Available Safety Data Sheets
CyFlow™ monoclonal antibodies SDS CA EN